ARTICLE | Clinical News
Genentech regulatory update
March 14, 1994 8:00 AM UTC
Genentech Inc. (GNE) GNE (South San Francisco) received FDA approval to market Nutropin human growth hormone to treat growth failure in children with inadequate levels of the natural hormone. This is...